Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Blockchain Africa Conference 2024 Witnesses Phenomenal Response

The 10th edition of the Blockchain Africa Conference was successfully hosted by Bitcoin Events at the CSIR International Convention Centre, on November 20, 2024, in Tshwane, South Africa. The in-person event witnessed around 500 attendees, which included an impressive line-up of dignitaries along with aspiring and established participants from the blockchain and cryptocurrency spectrum in Africa […]

Annovis Bio Inc. (NYSE: ANVS) Showcases 2024 Achievements and Strategic Vision in Year-End Investor Webcast

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company pioneering transformative therapies for neurodegenerative diseases, recently hosted its Year-End Investor Webcast, providing stakeholders with a comprehensive overview of the company’s 2024 milestones and strategic initiatives for 2025. The full webcast is available here: https://youtu.be/NA3kCUZZIpI. During the webcast, Dr. Maria Maccecchini, Founder, President, and CEO of […]

Clene Inc. (NASDAQ: CLNN) Receives FDA Guidance on Accelerated Approval Pathway for CNM-Au8(R) for ALS

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), has received additional written guidance and a roadmap from the U.S. Food and Drug Administration’s (“FDA”) Division […]

The Coretec Group Inc. (CRTG) Is ‘One to Watch’

The Coretec Group (OTCQB: CRTG) is a technology leader specializing in silicon-based solutions that advance energy storage, materials science and visualization technologies. Through cutting-edge developments like the Endurion program and CHS, the company is driving progress in electric vehicles (“EVs”), semiconductors and clean technology. Additionally, it is broadening its reach into 3D visualization with its […]

Adageis is Ramping Up Patient Care for All Healthcare Providers and Systems via a Powerful Patented AI-Centric Software

Adageis, a forward-thinking healthcare technology company, is reshaping patient care through flexible AI-centric software solutions for healthcare systems and providers, including accountable care organizations (“ACOs”), clinically integrated networks (“CINs”) and independent physician associations (“IPAs”). With a unique value proposition in the healthcare technology space, the company is actively improving healthcare delivery and increasing value-based care […]

Brera Holdings PLC (NASDAQ: BREA) Expands Global Portfolio with Strategic Investment in SS Juve Stabia SpA

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership approach, announced on Dec. 9 that it had committed to a strategic investment in SS Juve Stabia, the second team of Naples and a historic Italian Serie B football club. […]

Former PayPal COO to Head White House Crypto and AI Desk

On Thursday, the incoming U.S. President Donald Trump revealed that David Sacks, a former Chief Operations Officer at PayPal Holdings Inc. (NASDAQ: PYPL), had been chosen to be the “White House AI and Crypto Czar.” This announcement marks the latest step that the President-elect has taken in his bid to overhaul American policy on various […]

 

From Our Blog

Why 2026 Is a Pivotal Year for Private, Pre-IPO, and Microcap Investing, and What That Means for DealFlow Discovery

January 23, 2026

As we head into January 2026, the capital markets landscape is in a period of subtle but consequential transition, one that has real implications for the direction of private company financings, pre-public valuations, and the small-cap ecosystem that DealFlow Discovery Conference now reflects. For years, microcap investing sat at the intersection of retail enthusiasm and […]

Rotate your device 90° to view site.